Matthew Jones

Matthew Jones

Company: NextRNA Therapeutics

Job title: Head Of Platform Technology


Panel Discussion: What Makes a ‘Good’ RNA Target? 12:45 pm

Understanding how to find the best RNA target to drug the undruggable Which RNA structures would make suitable targets? How to achieve successful proof-of-concept with validated targets? Deciphering different validation levelsRead more

day: Pre-Conference Focus Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.